Inventor · disambiguated record
Ronny Mathieu Versteegen
Also filed as: VERSTEEGEN RONNY MATHIEU
14 granted patents·8 pending applications·119 citations·filing 2005–2023
92Inventor score
Files withTAGWORKS PHARMACEUTICALS B V14ROBILLARD MARC STEFAN3BOERAKKER MARK JOHANNES1ROSSIN RAFFAELLA1SIKKEMA DOETZE JAKOB1
Top patents by PatentIndex Score
22 records- 0194US9421274B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Aug 23, 2016·28 cites·4 claims
- 0294US7622131B2Siloxane polymers with quadruple hydrogen bonding unitsSUPRAPOLIX BV·Filed 2005·Granted Nov 24, 2009·30 cites·13 claims
- 0392US10376594B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2015·Granted Aug 13, 2019·11 cites·25 claims
- 0489US10004810B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2016·Granted Jun 26, 2018·6 cites·4 claims
- 0587US9427482B2Agents for clearing biomolecules from circulationROSSIN RAFFAELLA·Filed 2011·Granted Aug 30, 2016·19 cites·10 claims
- 0686US9931408B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Apr 3, 2018·7 cites·27 claims
- 0785US10967069B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2019·Granted Apr 6, 2021·1 cites·34 claims
- 0885US2024091371A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 0983US9913921B2Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a dieneROBILLARD MARC STEFAN·Filed 2012·Granted Mar 13, 2018·11 cites·4 claims
- 1081US10927139B2Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2013·Granted Feb 23, 2021·2 cites·37 claims
- 1176US11857636B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2021·Granted Jan 2, 2024·0 cites·17 claims
- 1273US11617799B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2017·Granted Apr 4, 2023·1 cites·41 claims
- 1371US8268952B2Supramolecular ionomersVAN GEMERT GABY MARIA LEONARDA·Filed 2005·Granted Sep 18, 2012·3 cites·27 claims
- 1467US12186405B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2022·Granted Jan 7, 2025·0 cites·33 claims
- 1563US2025114489A1Masked il12 proteinTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 1660US2021002320A1Chemically cleavable groupTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 1754US2024207434A1Methods for preparing cyclooctenes andconjugates thereofTAGWORKS PHARMACEUTICALS B V·Filed 2022·Application pending·0 cites
- 1851US2021308207A1Compounds comprising a linker for increasing transcyclooctene stabilityTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 1949US2022356169A1Tetrazines for high click release speed and yieldTAGWORKS PHARMACEUTICALS B V·Filed 2020·Application pending·0 cites
- 2047US2011301288A1Thioic acids as building block for polythioestersBOERAKKER MARK JOHANNES·Filed 2009·Application pending·0 cites
- 2146US2021299286A1Tetrazines for high click conjugation yield in vivo and high click release yieldTAGWORKS PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 2245US8299202B2Phenol compounds and (co)polymers thereofSIKKEMA DOETZE JAKOB·Filed 2009·Granted Oct 30, 2012·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →